COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations' Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth
Onco-Innovations Limited announces promising results in slowing colorectal cancer growth using nanoparticle PNKP Compound as standalone and combination treatment, targeting cancer cells precisely -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study
Onco-Innovations Limited introduces exclusive PNKP inhibitors to enhance sensitivity of cancer cells to radiation, potentially revolutionizing targeted cancer treatments -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations announces Expression of Interest with Quantify Research, a global healthcare data analytics leader, to explore collaborations in advanced data analytics and oncology research
